Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Pose

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Scientific Reports|September 1, 2016
Characterization of Inflammatory Response in Acute-on-Chronic Liver Failure and Relationship with PrognosisCristina Solé, Elsa Solà, Manuel Morales-Ruiz, et al.
Plos One|July 1, 2016
Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in CirrhosisIsabel Graupera, Elsa Solà, Núria Fabrellas, et al.
Hepatology (Baltimore, Md.)|January 9, 2021
The Use of Rifaximin in Patients With CirrhosisPaolo Caraceni, Victor Vargas, Elsa Solà, et al.
Hepatology (Baltimore, Md.)|August 25, 2023
Medications for alcohol use disorder promote abstinence in alcohol-associated cirrhosis: Results from a systematic review and meta-analysisJordi Gratacós-Ginès, Pol Bruguera, Martina Pérez-Guasch, et al.
United European Gastroenterology Journal|October 8, 2025
Marked Variation in Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease Over 5 Years: A Community-Based Study Using Controlled Attenuation ParameterMarta Cervera, Martina Pérez-Guasch, Marta Carol, et al.
Plos One|April 6, 2022
Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of lifeMarta Carol, Martina Pérez-Guasch, Elsa Solà, et al.
Hepatology (Baltimore, Md.)|February 9, 2018
Expression of microRNA-155 in inflammatory cells modulates liver injuryDelia Blaya, Beatriz Aguilar-Bravo, Fengjie Hao, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 15, 2021
Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF)Gabriel Mezzano, Andrés Cárdenas, Ferrán Aguilar, et al.
The Lancet Regional Health. Europe|June 10, 2026
Implementation of evidence-based alcohol policies to reduce alcohol-related harm and liver disease to advance public health in EuropeElisa Pose, Luis Antonio Díaz, Richard Parker, et al.
Clinical and Translational Gastroenterology|May 1, 2020
Psychological Burden of Hepatic Encephalopathy on Patients and CaregiversNúria Fabrellas, Rebeca Moreira, Marta Carol, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Scientific Reports|September 1, 2016
Characterization of Inflammatory Response in Acute-on-Chronic Liver Failure and Relationship with PrognosisCristina Solé, Elsa Solà, Manuel Morales-Ruiz, et al.
Plos One|July 1, 2016
Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in CirrhosisIsabel Graupera, Elsa Solà, Núria Fabrellas, et al.
Hepatology (Baltimore, Md.)|January 9, 2021
The Use of Rifaximin in Patients With CirrhosisPaolo Caraceni, Victor Vargas, Elsa Solà, et al.
Hepatology (Baltimore, Md.)|August 25, 2023
Medications for alcohol use disorder promote abstinence in alcohol-associated cirrhosis: Results from a systematic review and meta-analysisJordi Gratacós-Ginès, Pol Bruguera, Martina Pérez-Guasch, et al.
United European Gastroenterology Journal|October 8, 2025
Marked Variation in Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease Over 5 Years: A Community-Based Study Using Controlled Attenuation ParameterMarta Cervera, Martina Pérez-Guasch, Marta Carol, et al.
Plos One|April 6, 2022
Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of lifeMarta Carol, Martina Pérez-Guasch, Elsa Solà, et al.
Hepatology (Baltimore, Md.)|February 9, 2018
Expression of microRNA-155 in inflammatory cells modulates liver injuryDelia Blaya, Beatriz Aguilar-Bravo, Fengjie Hao, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 15, 2021
Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF)Gabriel Mezzano, Andrés Cárdenas, Ferrán Aguilar, et al.
The Lancet Regional Health. Europe|June 10, 2026
Implementation of evidence-based alcohol policies to reduce alcohol-related harm and liver disease to advance public health in EuropeElisa Pose, Luis Antonio Díaz, Richard Parker, et al.
Clinical and Translational Gastroenterology|May 1, 2020
Psychological Burden of Hepatic Encephalopathy on Patients and CaregiversNúria Fabrellas, Rebeca Moreira, Marta Carol, et al.
Pageof 10